Kenvue Inc
KVUE
View Detailed Chart
17.210USD
-0.120-0.69%
Close 12/15, 16:00（ET）Quotes delayed by 15 min
32.97BMarket Cap
23.02P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-0.69%
5 Days
+2.68%
1 Month
+3.30%
6 Months
-19.77%
Year to Date
-19.39%
1 Year
-22.51%
View Detailed Chart
TradingKey Stock Score of Kenvue Inc
Currency: USD Updated: 2025-12-15Key Insights
Kenvue Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 21/36 in the Personal & Household Products & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 19.55.In the medium term, the stock price is expected to remain stable.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Kenvue Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
15
analysts
Hold
Current Rating
19.547
Target Price
+16.63%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Kenvue Inc Highlights
StrengthsRisks
Kenvue Inc. is a consumer health company. The Company’s differentiated portfolio of brands includes Tylenol, Neutrogena, Listerine, Johnson’s, BAND-AID, Aveeno, Zyrtec, and Nicorette. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. Its Self Care product categories include pain care; cough, cold, and allergy; digestive health; smoking cessation; eye care; and other products. Self Care segments include brands such as Tylenol, Motrin, Nicorette, Benadryl, Zyrtec, Zarbee’s, ORSLTM, Rhinocort, and Calpol. The Skin Health and Beauty segment is focused on face and body care, as well as hair, sun, and other products. The Essential Health segment includes oral care, baby care, women’s health, wound care, and other products. Its portfolio includes Self Care, Skin Health and Beauty, and Essential Health products which connect with consumers across North America, Asia Pacific (APAC), Europe, Middle East, and Africa (EMEA), and Latin America (LATAM).
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 150.68%.
Fairly Valued
The company’s latest PE is 23.02, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 1.94B shares, decreasing 13.23% quarter-over-quarter.
Held by ETHSX
Star Investor ETHSX holds 42.02K shares of this stock.
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Kenvue Inc Info
Kenvue Inc. is a consumer health company. The Company’s differentiated portfolio of brands includes Tylenol, Neutrogena, Listerine, Johnson’s, BAND-AID, Aveeno, Zyrtec, and Nicorette. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. Its Self Care product categories include pain care; cough, cold, and allergy; digestive health; smoking cessation; eye care; and other products. Self Care segments include brands such as Tylenol, Motrin, Nicorette, Benadryl, Zyrtec, Zarbee’s, ORSLTM, Rhinocort, and Calpol. The Skin Health and Beauty segment is focused on face and body care, as well as hair, sun, and other products. The Essential Health segment includes oral care, baby care, women’s health, wound care, and other products. Its portfolio includes Self Care, Skin Health and Beauty, and Essential Health products which connect with consumers across North America, Asia Pacific (APAC), Europe, Middle East, and Africa (EMEA), and Latin America (LATAM).
Ticker SymbolKVUE
CompanyKenvue Inc
CEOPerry (Kirk L)
Websitehttps://www.kenvue.com
FAQs
What is the current price of Kenvue Inc (KVUE)?
The current price of Kenvue Inc (KVUE) is 17.210.
What is the symbol of Kenvue Inc?
The ticker symbol of Kenvue Inc is KVUE.
What is the 52-week high of Kenvue Inc?
The 52-week high of Kenvue Inc is 25.170.
What is the 52-week low of Kenvue Inc?
The 52-week low of Kenvue Inc is 14.020.
What is the market capitalization of Kenvue Inc?
The market capitalization of Kenvue Inc is 32.97B.
What is the net income of Kenvue Inc?
The net income of Kenvue Inc is 1.03B.
Is Kenvue Inc (KVUE) currently rated as Buy, Hold, or Sell?
According to analysts, Kenvue Inc (KVUE) has an overall rating of Hold, with a price target of 19.547.
What is the Earnings Per Share (EPS TTM) of Kenvue Inc (KVUE)?
The Earnings Per Share (EPS TTM) of Kenvue Inc (KVUE) is 0.748.
Related Instruments
+1.60%
+0.15%
+1.39%
-2.95%
-0.34%
+0.47%
-2.20%
-0.81%
+3.40%
+0.51%
-0.57%
+1.54%
+0.06%
+1.38%
+1.86%
+1.15%
-1.21%
-1.88%
-3.51%Popular Symbols
